Our study confirms that biallelic loss‐of‐function variants in MYL1 are associated with a consistent clinical and histopathological phenotype, which should be considered in individuals with severe congenital myopathy, particularly those with selective hypotrophy of type II fibres. This evidence concerns the gene MYL1 and congenital myopathy.